Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hai Kang Life Corporation Limited is currently addressing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This activity is situated within 1 distinct art unit and involves 1 distinct examiner. This arrangement reflects the status of the Biotechnology & Pharmaceuticals filings.
DUNN, MCKENZIE A is the busiest examiner for this entity. This official is responsible for 1 busiest examiner pending action. As the total number of pending office actions is 1, this examiner handles the workload for the company. This setup enables a consistent review of the submitted claims.
The 1 distinct examiner and 1 distinct art unit involved suggest that the portfolio has a focus at this time. For a practitioner, the outcome of the pending matters will impact the standing of the Hai Kang Life Corporation Limited portfolio. The current efforts are directed toward the case under DUNN, MCKENZIE A. This examiner manages the 1 busiest examiner pending action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DUNN, MCKENZIE A | 1 | 53.8% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18127887 | IMAGE QUANTIFICATION SYSTEM FOR ESTIMATION OF VIRAL LOAD BASED ON DETECTION BY RAPID ANTIGEN TEST | DUNN, MCKENZIE A | 23d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18127887 | IMAGE QUANTIFICATION SYSTEM FOR ESTIMATION OF VIRAL LOAD BASED ON DETECTION BY RAPID ANTIGEN TEST | DUNN, MCKENZIE A | 23d overdue |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18127887 | IMAGE QUANTIFICATION SYSTEM FOR ESTIMATION OF VIRAL LOAD BASED ON DETECTION BY RAPID ANTIGEN TEST | DUNN, MCKENZIE A | 1678 | §103§112 | Final Rejection | 23d overdue | Pending | Mar 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial